Creator's evidence scores for omega-3 fish oil: heart, cognition and aging clocks

🎬 EPISODE OVERVIEW Does your fish oil capsule deserve its reputation? In Episode 31, I review omega-3s for heart health, cognition, and healthy aging, then give five evidence scores and an overall C+. We examine VITAL, REDUCE-IT, STRENGTH, newer DHA research, aging clocks, and safety. Eating fish, taking supplements, and using prescription omega-3s are different questions. 🔑 KEYWORDS Omega-3 • Fish Oil • EPA • DHA • Triglycerides • Cognition • Aging Clocks • Atrial Fibrillation • Longevity 📌 KEY TAKEAWAYS • Triglyceride lowering: 5/5 at studied therapeutic doses. • Routine cardiovascular prevention in generally healthy adults: 2/5. Prescription EPA in selected high-risk patients is a separate clinical decision. • Preventing cognitive decline in generally healthy older adults: 1/5. • Epigenetic aging clocks: 2/5. Small changes in clock estimates do not establish longer life. • Extending human lifespan through routine supplementation: 1/5. • Overall: C+ for routine OTC fish oil as a healthy-aging intervention; this is my assessment, not a mathematical average. Dose, formulation, and baseline risk matter. 🎙️ THE REPROGRAM PERSPECTIVE A biological mechanism or improved test result is a starting point. Ask whether the evidence shows better health, function, or survival in people like you. Educational discussion; understand prescribed treatment with your clinician before making changes. ⏱️ CHAPTERS 00:00 What has fish oil earned? 00:55 The Scorecard framework 01:16 Fish, supplements, and prescription products 01:56 Read the EPA and DHA label 02:27 Triglycerides: the strongest evidence 03:43 VITAL and heart prevention 04:39 REDUCE-IT and prescription EPA 05:50 STRENGTH and conflicting results 07:08 Brain health and the DHA trials 08:34 DO-HEALTH and aging clocks 09:59 Heart-rhythm risk and interactions 11:37 Five claims, five scores 13:22 The C+ verdict and its limits 14:27 Questions to ask about your supplement 15:31 Closing perspective 📝 NOTES AND REFERENCES 1. NIH ODS. Omega-3 fatty acids: background and labeling. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/ 2. Skulas-Ray et al. AHA triglyceride advisory (2019). https://doi.org/10.1161/CIR.0000000000000709 3. Manson et al. VITAL cardiovascular trial (2019). https://doi.org/10.1056/NEJMoa1811403 4. Bhatt et al. REDUCE-IT (2019). https://doi.org/10.1056/NEJMoa1812792 5. Nicholls et al. STRENGTH (2020). https://doi.org/10.1001/jama.2020.22258 6. Abdelhamid et al. Cochrane cardiovascular review (2020). https://doi.org/10.1002/14651858.CD003177.pub5 7. Kang et al. VITAL cognitive study (2021). https://pmc.ncbi.nlm.nih.gov/articles/PMC8984093/ 8. Yassine et al. DHA target engagement and cognition (2026). https://doi.org/10.1016/j.ebiom.2026.106316 9. Bischoff-Ferrari et al. DO-HEALTH aging clocks (2025). https://doi.org/10.1038/s43587-024-00793-y 10. Abuknesha et al. Omega-3s and atrial fibrillation (2026). https://doi.org/10.1161/CIRCEP.125.014785 11. ACC/AHA et al. Dyslipidemia guideline (2026). https://doi.org/10.1161/CIR.0000000000001423 💬 JOIN THE CONVERSATION If you take fish oil, what benefit are you hoping for—and does the evidence match that goal? Subscribe to The ReProgram: https://www.youtube.com/@ReProgramPodcast Longevity Biology Without the Hype. Mechanism over marketing. Evidence over anecdotes. Trade-offs over hype.